AI assistant
Traws Pharma, Inc. — Director's Dealing 2013
Jul 25, 2013
35199_dirs_2013-07-24_a091c303-9c0a-4dfe-9484-1f6a0abe6f8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-24
Reporting Person: MCKEARN THOMAS J (President, R&D)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to purchase) | $7.53 | 2022-03-10 | Common Stock (893) | Direct | |
| Stock Option (right to purchase) | $13.28 | 2022-09-01 | Common Stock (412) | Direct | |
| Stock Option (right to purchase) | $13.28 | 2022-12-19 | Common Stock (75018) | Direct | |
| Stock Option (right to purchase) | $13.28 | 2023-03-21 | Common Stock (78769) | Direct |
Footnotes
F1: This option, representing a right to purchase a total of 75,018 shares of Common Stock, is immediately exercisable and vests over 4 years from December 18, 2012, with 25% vesting on December 18, 2013 and 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.
F2: This option, representing a right to purchase a total of 78,769 shares of Common Stock, is immediately exercisable and vests over 4 years from March 20, 2013, with 25% vesting on March 20, 2014 and 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.